← Back to Search

Intervention for Frailty

N/A
Recruiting
Led By Scott M Dresden, MD, MS
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will test whether adding a specialized team to care for older adults in the emergency department improves care and outcomes.

Who is the study for?
This trial is for older adults aged 65 or above who are living independently or with others, can provide informed consent, and have a Clinical Frailty Scale score of at least 4. It's not for those in critical condition, non-urgent cases, enrolled in another study, unable to follow-up or complete assessments in English, COVID-19 positive patients, prisoners, psychiatric holds or if they've had certain consultations outside the trial.Check my eligibility
What is being tested?
The study tests the Geriatric Emergency Department Innovations (GEDI) program. Participants will either receive care from a standard emergency department team plus GEDI specialists or just the usual emergency care. The aim is to see if adding GEDI improves outcomes for frail older adults.See study design
What are the potential side effects?
Since this trial involves an additional care program rather than medication there may be no direct side effects like with drugs; however participants might experience discomfort due to increased interaction/intervention by the healthcare team.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Death
Number of patients admitted
Number of patients with hospital admission or death
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Standard emergency department are plus GEDI consult
Group II: ControlActive Control1 Intervention
Standard emergency department care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,411 Total Patients Enrolled
5 Trials studying Frailty
1,141 Patients Enrolled for Frailty
Scott M Dresden, MD, MSPrincipal InvestigatorNorthwestern University Department of Emergency Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open spots for individuals to join this trial?

"Per the information available on clinicaltrials.gov, participation in this medical trial is open to new recruits. The study was first published on October 7th 2019 and has been updated most recently as of March 18th 2022."

Answered by AI

How expansive is the recruitment of participants for this trial?

"Correct. The clinicialtrials.gov website shows this medical trial is actively recruiting, with the first post being dated October 7th 2019 and most recent update on March 18th 2022. 840 participants need to be found at a single clinical site."

Answered by AI
~142 spots leftby Mar 2025